Alginor key facts
as of Oct 2026- Manufacturer of kelp-based life science ingredients intended to offer sustainable materials.
- Alginor is valued at approximately $101.1M as of Oct 2026 (last reported valuation).
- It has raised $300.4M; the latest was Debt - General ($23.1M) in Oct 2025.
- Notable investors include European Innovation Council, Must Invest, Profond (Norway), AMAR INVEST I, BNP Paribas — 20 tracked in total.
- Status: Privately Held (backing).
Alginor's last reported valuation, Jun 2024. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch Alginor: the Monday email on marks, rounds and moves
Alginor funding rounds
No funding rounds for Alginor are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Alginor
20+Alginor valuation
Alginor's last reported valuation was $101 million in Jun 2024. No priced round, secondary trade or fund mark has surfaced since.
Alginor investors
20 investors are on record for Alginor, including European Innovation Council, Must Invest, Profond (Norway) and AMAR INVEST I.
About Alginor
Manufacturer of kelp-based life science ingredients intended to offer sustainable materials. The company harvests and biorefines Laminaria Hyperborea to offer mannitol, fucoidan, cellulose, alginate, oligosaccharides, polyphenols, carotenoids, amino acids, savory, laminarin, biobased materials, and borea powder, enabling companies to produce without downstream waste and zero formaldehyde.
- Sector
- Business Products and Services (B2B)
- HQ
- Avaldsnes, Norway
- Founded
- 2014
- Employees
- 50
- Website
- alginor.no/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.